课题基金 / 基金详情

hiPSC-based DRG Tissue Mimics on Multi-well Microelectrode Arrays as a Tissue Chip Model of Acute and Chronic Nociception

hiPSC-based DRG Tissue Mimics on Multi-well Microelectrode Arrays as a Tissue Chip Model of Acute and Chronic Nociception
基于 hiPSC 的多孔微电极阵列上的 DRG 组织模拟作为急性和慢性伤害感受的组织芯片模型
批准号:
10254878
负责人:
Bryan James Black
金额:
$60.12万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-13 至 2021-09-13

项目摘要

项目成果

Bryan James Black的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要/摘要: 慢性疼痛困扰着多达五分之一的成年人,是导致老年人长期残疾的最常见原因 世界。阿片类药物通常用于治疗非癌症疼痛,与高发病率有关。 严重的影响和滥用。此外,目前用于研究伤害性感受和测试的体内和体外模型 潜在的治疗方法是不够的。基于人类的、与病理相关的伤害性感受模型迫在眉睫 需要促进新的非阿片类止痛药的临床前开发。因此,我们建议 利用HiPSC感觉神经元和卫星建立急性和慢性伤害性感受的创新3D模型 多孔MEA上的胶质细胞替代物(一种基于HiPSC的DRG组织模拟物)。 在UG3阶段,我们将开发一种基于3D的组织芯片,用于模拟急慢性伤害性感受 基于HiPSC的背根节(DRG)组织模拟和高含量、中等通量微电极 阵列(MEA)平台。DRG组织模拟物将由构成神经节内的HiPSC对应物组成 植入胶原蛋白基质的DRG细胞类型。然后,我们将展示稳定、自发和有害的 对热、化学和电刺激挑战作出反应的刺激诱发行为。此外, 我们的目标是展示利用3D混合细胞背根神经节组织的明确的功能和表型优势 模拟与纯神经元2D或3D模型。更具体地说,我们的目标是展示对 通过神经元和非神经元细胞之间的配体受体相互作用进行翻译控制,从而 显示出与疼痛(伤害性、炎症性和神经性)三位一体的病理相关性 以及我们的模型对与非神经元支持的贡献相关的基本假设的测试能力 细胞在慢性疼痛的发展和维持中的作用。 在UH3阶段,我们将展示我们的强大的量化效率和临床前疗效 通过检测已知的基于配体的翻译控制和电压调节因子来构建微生理系统 慢性伤害性致敏模型中的门控离子通道拮抗剂。这两类药物是 被广泛认为是逆转伤害性可塑性和/或作为外周神经的候选化合物 止痛药。此外,我们将根据被广泛接受的化验评分来定量定义药理作用。 方法论。最后,我们将利用高通量的性质或我们的组织芯片模型来筛选FDA- 经批准的生物活性化合物,证明了我们高含量检测的灵敏度和吞吐量,以及 潜在地识别候选疗法的疗效被不那么复杂的表型方法所掩盖 放映。
英文摘要
Project summary/abstract: Chronic pain afflicts up to one in five adults and is the most common cause of long-term disability in the world. Opioids, which are commonly prescribed for non-cancer pain, are associated with a high incidence of serious effects and abuse. Moreover, current in vivo and in vitro models used to study nociception and test potential treatments are inadequate. Human-based, pathology-relevant models of nociception are urgently needed to facilitate preclinical development of new non-opioid pain therapeutics. Therefore, we propose to develop an innovative 3D model of acute and chronic nociception using hiPSC sensory neurons and satellite glial cell surrogates (an hiPSC-based DRG tissue mimic) on multi-well MEAs. In the UG3 phase, we will develop a tissue chip for modeling acute and chronic nociception based on 3D hiPSC-based dorsal root ganglion (DRG) tissue mimics and a high-content, moderate-throughput microelectrode array (MEA) platform. DRG tissue mimics will be comprised of hiPSC counterparts to constituent intraganglionic DRG cell types embedded in a collagen matrix. We will then demonstrate stable spontaneous and noxious stimulus-evoked behavior in response to thermal, chemical, and electrical stimulation challenges. Furthermore, we aim to demonstrate the clear functional and phenotypic advantages of utilizing a 3D mixed-cell DRG tissue mimic versus purely neuronal 2D or 3D models. More specifically, we aim to demonstrate sensitivity to translational control via ligand receptor interactions between neuronal and non-neuronal cell types, thereby demonstrating pathological relevance to a the ‘holy trinity’ of pain (nociceptive, inflammatory and neuropathic) and our model’s capacity for testing fundamental hypotheses related to contributions of non-neuronal support cells in chronic pain development and maintenance. In the UH3 phase, we will demonstrate the powerful quantitative efficiency and preclinical efficacy of our microphysiological system by detecting known ligand-based modulators of translational control and voltage- gated ion channel antagonists in a sensitized model of chronic nociception. These two classes of drugs are widely recognized as candidate compounds for reversing nociceptive plasticity and/or serving as peripheral analgesics. Moreover, we will quantitatively define pharmacological hits based on widely accepted assay scoring methodologies. Lastly, we will leverage the high-throughput nature or our tissue chip model to screen FDA- approved, bioactive compounds, demonstrating the sensitivity and throughput of our high content assay, and potentially identifying efficacy of candidate therapeutics obscured by less sophisticated methods of phenotypic screening.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
hiPSC-based DRG Tissue Mimics on Multi-well Microelectrode Arrays as a Tissue Chip Model of Acute and Chronic Nociception
hiPSC-based DRG Tissue Mimics on Multi-well Microelectrode Arrays as a Tissue Chip Model of Acute and Chronic Nociception
国内基金
海外基金
Data-driven Recommendation System Construction of an Online Medical Platform Based on the Fusion of Information
Incentive and governance schenism study of corporate green washing behavior in China: Based on an integiated view of econfiguration of environmental authority and decoupling logic
  • 批准号:
    --
  • 项目类别:
    外国学者研究基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    YU BYUNGJUN
  • 依托单位:
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
  • 批准号:
    W2433169
  • 项目类别:
    外国学者研究基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    HAOFEI ZHANG
  • 依托单位:
含Re、Ru先进镍基单晶高温合金中TCP相成核—生长机理的原位动态研究
  • 批准号:
    52301178
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    夏万顺
  • 依托单位: